摘要
At present, autologous stem cell transplantation (ASCT) is considered as an optional consolidation therapy for natural killer/T-cell lymphoma (NKTCL). However, the high-risk patients undergoing ASCT are not clear enough. In this study, 56 patients with advanced staged or relapsed/refractory (R/R) NKTCL undergoing ASCT were reviewed. All patients achieved clinical complete response (CR) before ASCT. The median follow-up time was 36 months (range, 3-192 months). The three-year overall survival (OS) and three-year progression-free survival (PFS) were 70.2% and 56.5%, respectively. The independent prognostic factors for OS included prior testis involvement and pre-ASCT EBV-DNA. Patients without prior testis involvement and negative pre-ASCT EBV-DNA (group A) had better three-year OS (86.3% vs. 47.6%,p < .001) than the rest patients (group B). In conclusion, our study suggests that testis involvement and elevated EBV-DNA might be strong adverse prognostic factors for NKTCL. Patients without the above risk factors are more likely to benefit from ASCT.
学科与关键词
- CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without AsparaginaseYang, Jing; Li, Pengfei; Piao, Yingshi; Liu, Xindi; Wei, Liqiang; Sang, Wei*; Zhang, Luo*; Wang, Liang*Frontiers in Immunology, 2022, 13: 829366.被引 1
- Low absolute CD4+ T cell counts in peripheral blood: an independent predictor of inferior survival in natural killer/T-cell lymphoma-a retrospective cohort studyZeng, Ruifang; Zhu, Wenzhuo; Jiang, Li; Zhu, Xi; Gao, Yan; Xia, Yi; Bai, Bing; Shikama, Naoto; Janetos, Timothy M.; Dalia, Samir; Alpdogan, Onder; Wang, Xiaoxiao; Zhu, Lingling*; Li, Pengfei*Annals of Translational Medicine, 2022, 10(20): 1119.
- The Prognostic Value of Dynamic Change of NK-Cell Counts in Diffuse Large B-Cell Lymphoma Treated with R-CHOPHuan, Chen; Zheng, Zhongxin; Wei, Yongqiang; Guo, Xutao; Wei, Qi; Feng, Ru; Wei, Xiaolei65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
